Compare across cohorts, time points, and studies, empowered by precise absolute quantification. Generate rich, robust data from just a few microlitres of plasma or cerebral spinal fluid, maximizing the value of each precious sample.

Designed in partnership with field experts, biobanks, and publications to prioritize markers with translational potential, Target 48 Neurodegeneration panel covers mechanisms critical to interrogate disease progression and further understanding of leading neuro disorders such as Alzheimer’s, Parkinson’s, and multiple sclerosis.

Quantify pTau217, Aβ40, Aβ42, NfL, GFAP, and more in a single, scalable assay—saving time, cost, and precious patient sample.

Download Target 48 Neurodegeneration Assay list

Beyond the Olink panel lies a wide range of free tools for study design, statistical analysis, data visualization and quality control. There’s also continuous support from our data science experts and customer service teams. We’re proud to be active partners to thousands of researchers, from small lab teams to major institutions and consortia.

Below you will find a few documents related to this product. For the complete documentation including SDS, user manuals, technical notes and more, visit the documents section.